Real-world Safety and Effectiveness of Sotrovimab in Japanese Patients with SARS-CoV-2 Infection: Final Report of General Drug Use Investigation

Authors

Institutions

Publication Details

Journal
Kansenshogaku zasshi
Published
2024-12-23
DOI
https://doi.org/10.11150/kansenshogakuzasshi.e24008
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world Safety and Effectiveness of Sotrovimab in Japanese Patients with SARS-CoV-2 Infection: Final Report of General Drug Use Investigation

Kenji Oda, Yoshiaki Kawano, Naohiro Takahashi, Yasuyo Nose et al.
Kansenshogaku zasshi
COVID-19 Clinical Research Studies
article

Real-world Safety and Effectiveness of Sotrovimab in Japanese Patients with SARS-CoV-2 Infection: Final Report of General Drug Use Investigation

Kenji Oda, Yoshiaki Kawano, Naohiro Takahashi, Yasuyo Nose, Yutaka Handa, Takuma DANJO, Hiroko Mizohata, Akemi KANEUCHI
article en

Abstract

No abstract available for this paper.
Kansenshogaku zasshiVol. 99(1)
GlaxoSmithKline (Japan) (JP)
Good health and well-being
Openalex Percentile: Top 70%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-world Safety and Effectiveness of Sotrovimab in Japanese Patients with SARS-CoV-2 Infection: Final Report of General Drug Use Investigation — Kenji Oda, Yoshiaki Kawano, et al. · Kansenshogaku zasshi (2024) | TGRS Research Map | TGRS